Pleural diseases affect the pleural tissue that lines the inside of the chest cavity and covers the outside of the lungs. The visceral pleura (which covers the lung) and the parietal pleura (which ...

In a human body, pleura is a large thin layer of tissue that wraps around the outside of your lungs and lines the inside of your chest cavity. There is a potential thin space named pleural space ...

The ambiguity in medical imaging can present major challenges for clinicians who are trying to identify disease. For instance, in a chest X-ray, pleural effusion, an abnormal buildup of fluid in the ...

To develop a method to deliver mesenchymal stem cells (MSCs) into the pleural cavity for the treatment of pleural diseases. MSCs were isolated from rat bone marrow of rats and labeled with ...

Lung Therapeutics has raised a $36 million series C round to take a treatment for a serious complication of pneumonia through phase 2 studies. Texas-based Lung Therapeutics is built on the research of ...

Interventional pulmonologists are highly trained specialists who use advanced, non-surgical therapies to treat your respiratory system. Interventional pulmonologists have experience with a broad range ...

The Key Pleural Diseases Companies in the market include - Istituto Oncologico Veneto, RS Oncology, PrECOG, LLC, AstraZeneca, Oncotelic Inc., Trizell Ltd, MedImmune LLC, Sanofi, and others.

New York, United States , June 22, 2024 (GLOBE NEWSWIRE) -- The Global Pleural Diseases Market Size is to Grow from USD 5.0 Billion in 2023 to USD 9.61 Billion by 2033, at a CAGR of 6.75% during the ...

The global market for pleural diseases therapeutics is projected to experience steady growth over the next decade, with an estimated valuation of USD 4.98 billion in 2023. According to the latest ...